# AZD2624 Multiple Ascending Dose Study in Japan

> **NCT00696865** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 30 (estimated)

## Conditions studied

- Healthy
- Safety

## Interventions

- **DRUG:** AZD2624
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00696865
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** —
- **Final completion:** 2008-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696865, "AZD2624 Multiple Ascending Dose Study in Japan". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00696865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*